Ron Milo - Publications

Affiliations: 
Plant Science Weizmann Institute of Science, Rehovot, Israel 

163 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Alves R, Salvadó B, Milo R, Vilaprinyo E, Sorribas A. Maximization of information transmission influences selection of native phosphorelay architectures. Peerj. 9: e11558. PMID 34178454 DOI: 10.7717/peerj.11558  0.01
2021 Leger D, Matassa S, Noor E, Shepon A, Milo R, Bar-Even A. Photovoltaic-driven microbial protein production can use land and sunlight more efficiently than conventional crops. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34155098 DOI: 10.1073/pnas.2015025118  0.01
2021 Sender R, Bar-On YM, Gleizer S, Bernshtein B, Flamholz A, Phillips R, Milo R. The total number and mass of SARS-CoV-2 virions. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34083352 DOI: 10.1073/pnas.2024815118  0.01
2021 Radomir L, Kramer MP, Perpinial M, Schottlender N, Rabani S, David K, Wiener A, Lewinsky H, Becker-Herman S, Aharoni R, Milo R, Mauri C, Shachar I. The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5. Nature Communications. 12: 1893. PMID 33767202 DOI: 10.1038/s41467-021-22230-z  0.01
2021 Boyko A, Therapontos C, Horakova D, Szilasiová J, Kalniņa J, Kolontareva J, Gross-Paju K, Selmaj K, Sereike I, Milo R, Gabelić T, Rot U. Approaches and challenges in the diagnosis and management of secondary progressive multiple sclerosis: A Central Eastern European perspective from healthcare professionals. Multiple Sclerosis and Related Disorders. 50: 102778. PMID 33592384 DOI: 10.1016/j.msard.2021.102778  0.01
2021 Sender R, Milo R. The distribution of cellular turnover in the human body. Nature Medicine. 27: 45-48. PMID 33432173 DOI: 10.1038/s41591-020-01182-9  0.01
2021 Alkrenawi M, Osherov M, Simonovich A, Droujin J, Milo R, Appel S. Association between cervical disc disease and lesions of multiple sclerosis. The Neuroradiology Journal. 1971400920983565. PMID 33393859 DOI: 10.1177/1971400920983565  0.01
2020 Elhacham E, Ben-Uri L, Grozovski J, Bar-On YM, Milo R. Global human-made mass exceeds all living biomass. Nature. PMID 33299177 DOI: 10.1038/s41586-020-3010-5  0.01
2020 Sender R, Bar-On YM, Flamholz A, Gleizer S, Bernsthein B, Phillips R, Milo R. The total number and mass of SARS-CoV-2 virions in an infected person. Medrxiv : the Preprint Server For Health Sciences. PMID 33236021 DOI: 10.1101/2020.11.16.20232009  0.01
2020 Flamholz AI, Dugan E, Blikstad C, Gleizer S, Ben-Nissan R, Amram S, Antonovsky N, Ravishankar S, Noor E, Bar-Even A, Milo R, Savage D. Functional reconstitution of a bacterial CO concentrating mechanism in . Elife. 9. PMID 33084575 DOI: 10.7554/eLife.59882  0.04
2020 Davidi D, Shamshoum M, Guo Z, Bar-On YM, Prywes N, Oz A, Jablonska J, Flamholz A, Wernick DG, Antonovsky N, de Pins B, Shachar L, Hochhauser D, Peleg Y, Albeck S, ... ... Milo R, et al. Highly active rubiscos discovered by systematic interrogation of natural sequence diversity. The Embo Journal. e104081. PMID 32500941 DOI: 10.15252/Embj.2019104081  0.01
2020 Solari A, Giordano A, Sastre-Garriga J, Köpke S, Rahn AC, Kleiter I, Aleksovska K, Battaglia MA, Bay J, Copetti M, Drulovic J, Kooij L, Mens J, Meza Murillo ER, Milanov I, ... Milo R, et al. EAN guideline on palliative care of people with severe, progressive multiple sclerosis. European Journal of Neurology. PMID 32469447 DOI: 10.1111/Ene.14248  0.01
2020 Solari A, Giordano A, Sastre-Garriga J, Köpke S, Rahn AC, Kleiter I, Aleksovska K, Battaglia MA, Bay J, Copetti M, Drulovic J, Kooij L, Mens J, Meza Murillo ER, Milanov I, ... Milo R, et al. EAN Guideline on Palliative Care of People with Severe, Progressive Multiple Sclerosis. Journal of Palliative Medicine. PMID 32469284 DOI: 10.1089/Jpm.2020.0220  0.01
2020 Nitsan Z, Cohen OS, Chapman J, Kahana E, Korczyn AD, Appel S, Osherov M, Rosenmann H, Milo R. Familial Creutzfeldt-Jakob disease homozygous to the E200K mutation: clinical characteristics and disease course. Journal of Neurology. PMID 32367297 DOI: 10.1007/S00415-020-09826-Z  0.01
2020 Bar-On YM, Flamholz A, Phillips R, Milo R. SARS-CoV-2 (COVID-19) by the numbers. Elife. 9. PMID 32228860 DOI: 10.7554/Elife.57309  0.01
2020 Bar-On YM, Flamholz A, Phillips R, Milo R. Author response: SARS-CoV-2 (COVID-19) by the numbers Elife. DOI: 10.7554/Elife.57309.Sa2  0.01
2019 Bar-On YM, Milo R. The Biomass Composition of the Oceans: A Blueprint of Our Blue Planet. Cell. 179: 1451-1454. PMID 31835026 DOI: 10.1016/J.Cell.2019.11.018  0.01
2019 Gleizer S, Ben-Nissan R, Bar-On YM, Antonovsky N, Noor E, Zohar Y, Jona G, Krieger E, Shamshoum M, Bar-Even A, Milo R. Conversion of Escherichia coli to Generate All Biomass Carbon from CO. Cell. 179: 1255-1263.e12. PMID 31778652 DOI: 10.1016/J.Cell.2019.11.009  0.01
2019 Bachar A, Itzhaki E, Gleizer S, Shamshoom M, Milo R, Antonovsky N. Point mutations in topoisomerase I alter the mutation spectrum in E. coli and impact the emergence of drug resistance genotypes. Nucleic Acids Research. PMID 31777935 DOI: 10.1093/Nar/Gkz1100  0.01
2019 Milo R, Korczyn AD, Manouchehri N, Stüve O. The temporal and causal relationship between inflammation and neurodegeneration in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519886943. PMID 31682184 DOI: 10.1177/1352458519886943  0.04
2019 Rommer PS, Milo R, Han MH, Satyanarayan S, Sellner J, Hauer L, Illes Z, Warnke C, Laurent S, Weber MS, Zhang Y, Stuve O. Immunological Aspects of Approved MS Therapeutics. Frontiers in Immunology. 10: 1564. PMID 31354720 DOI: 10.3389/Fimmu.2019.01564  0.01
2019 Flamholz AI, Prywes N, Moran U, Davidi D, Bar-On Y, Alves R, Oltrogge L, Savage DF, Milo R. Revisiting tradeoffs between Rubisco kinetic parameters. Biochemistry. PMID 31259528 DOI: 10.1021/Acs.Biochem.9B00237  0.01
2019 Milo R, Karussis D. [MULTIPLE SCLEROSIS THERAPY - 2019]. Harefuah. 158: 388-394. PMID 31215192  0.01
2019 Milo R. Therapies for multiple sclerosis targeting B cells. Croatian Medical Journal. 60: 87-98. PMID 31044580 DOI: 10.3325/Cmj.2019.60.87  0.01
2019 Zuckerman NS, Indenbaum V, Milo R, Mendelson E, Lustig Y. JC virus identified in a patient with persistent and severe West Nile virus disease. Journal of Neurovirology. 25: 608-611. PMID 30949974 DOI: 10.1007/S13365-019-00744-Z  0.01
2019 Bar-On YM, Milo R. Towards a quantitative view of the global ubiquity of biofilms. Nature Reviews. Microbiology. 17: 199-200. PMID 30792541 DOI: 10.1038/S41579-019-0162-0  0.01
2019 Bar-On YM, Milo R. The global mass and average rate of rubisco. Proceedings of the National Academy of Sciences of the United States of America. PMID 30782794 DOI: 10.1073/Pnas.1816654116  0.01
2018 Weill U, Krieger G, Avihou Z, Milo R, Schuldiner M, Davidi D. Assessment of GFP Tag Position on Protein Localization and Growth Fitness in Yeast. Journal of Molecular Biology. PMID 30550779 DOI: 10.1016/J.Jmb.2018.12.004  0.01
2018 Davidi D, Longo LM, Jabłońska J, Milo R, Tawfik DS. A Bird's-Eye View of Enzyme Evolution: Chemical, Physicochemical, and Physiological Considerations. Chemical Reviews. PMID 30133258 DOI: 10.1021/Acs.Chemrev.8B00039  0.01
2018 Appel S, Gelfand A, Kotlyar G, Milo R. A retrospective analysis of the development of seizure frequency in patients with seizures during a period of military conflict. Seizure. 61: 119-121. PMID 30125863 DOI: 10.1016/J.Seizure.2018.08.003  0.01
2018 Köpke S, Giordano A, Veronese S, Rahn AC, Kleiter I, Basedow-Rajwich B, Fornari A, Battaglia MA, Drulovic J, Kooij L, Koops J, Mens J, Meza Murillo ER, Milanov I, Milo R, et al. Patient and caregiver involvement in formulation of guideline questions: Findings from the EAN Guideline on Palliative Care of People with Severe Multiple Sclerosis. European Journal of Neurology. PMID 30035845 DOI: 10.1111/Ene.13760  0.01
2018 Bar-On YM, Phillips R, Milo R. The biomass distribution on Earth. Proceedings of the National Academy of Sciences of the United States of America. PMID 29784790 DOI: 10.1073/Pnas.1711842115  0.01
2018 Shepon A, Eshel G, Noor E, Milo R. The opportunity cost of animal based diets exceeds all food losses. Proceedings of the National Academy of Sciences of the United States of America. 115: 3804-3809. PMID 29581251 DOI: 10.1073/Pnas.1713820115  0.01
2018 Eshel G, Shepon A, Shaket T, Cotler BD, Gilutz S, Giddings D, Raymo ME, Milo R. A model for 'sustainable' US beef production. Nature Ecology & Evolution. 2: 81-85. PMID 29203916 DOI: 10.1038/S41559-017-0390-5  0.01
2018 Nitsan Z, Kucuk N, Appel S, Tichmanovich N, Osherov M, Milo R. Mycosis fungoides - A cutaneous lymphoproliferative disorder in a patient treated with fingolimod for multiple sclerosis. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 48: 102-103. PMID 29108666 DOI: 10.1016/J.Jocn.2017.10.077  0.01
2017 Herz E, Antonovsky N, Bar-On Y, Davidi D, Gleizer S, Prywes N, Noda-Garcia L, Lyn Frisch K, Zohar Y, Wernick DG, Savidor A, Barenholz U, Milo R. The genetic basis for the adaptation of E. coli to sugar synthesis from CO2. Nature Communications. 8: 1705. PMID 29167457 DOI: 10.1038/S41467-017-01835-3  0.01
2017 Osherov M, Milo R. Daclizumab for the treatment of adults with relapsing forms of multiple sclerosis. Expert Review of Clinical Pharmacology. 10: 1037-1047. PMID 28803486 DOI: 10.1080/17512433.2017.1366854  0.01
2017 Antonovsky N, Gleizer S, Milo R. Engineering carbon fixation in E. coli: from heterologous RuBisCO expression to the Calvin-Benson-Bassham cycle. Current Opinion in Biotechnology. 47: 83-91. PMID 28715702 DOI: 10.1016/J.Copbio.2017.06.006  0.01
2017 Pollak L, Zehavi-Dorin T, Eyal A, Milo R, Huna-Baron R. Parinaud syndrome: Any clinicoradiological correlation? Acta Neurologica Scandinavica. 136: 721-726. PMID 28653396 DOI: 10.1111/Ane.12795  0.01
2017 Mahmoudabadi G, Milo R, Phillips R. Energetic cost of building a virus. Proceedings of the National Academy of Sciences of the United States of America. PMID 28512219 DOI: 10.1073/Pnas.1701670114  0.01
2017 Milo R, Osherov M. Daclizumab and its use in multiple sclerosis treatment. Drugs of Today. 53: 7-18. PMID 28387383 DOI: 10.1358/Dot.2017.53.1.2570979  0.01
2017 Davidi D, Milo R. Lessons on enzyme kinetics from quantitative proteomics. Current Opinion in Biotechnology. 46: 81-89. PMID 28288339 DOI: 10.1016/J.Copbio.2017.02.007  0.01
2017 Barenholz U, Davidi D, Reznik E, Bar-On Y, Antonovsky N, Noor E, Milo R. Design principles of autocatalytic cycles constrain enzyme kinetics and force low substrate saturation at flux branch points. Elife. 6. PMID 28169831 DOI: 10.7554/Elife.20667  0.01
2017 Barenholz U, Davidi D, Reznik E, Bar-On Y, Antonovsky N, Noor E, Milo R. Author response: Design principles of autocatalytic cycles constrain enzyme kinetics and force low substrate saturation at flux branch points Elife. DOI: 10.7554/Elife.20667.013  0.01
2017 Appel S, Nitsan Z, Gelfand A, Tikhmanovich N, Dorodnicov E, Reznik‐Zoref J, Milo R, Lugassy G, Simonovich A. Progressive multifocal leukoencephalopathy in a patient with chronic lymphocytic leukemia after immunosuppressive treatment Neurology and Clinical Neuroscience. 5: 29-31. DOI: 10.1111/Ncn3.12086  0.01
2017 Pollak L, Zehavi-Dorin T, Ana E, Milo R, Huna-Baron R. Parinaud syndrome: Any clinicoradiological correlation? Journal of the Neurological Sciences. 381: 483. DOI: 10.1016/J.Jns.2017.08.3568  0.01
2017 Dorodnicov E, Nasi V, Milo R, Bilenko N. Efficacy of "alarm stroke code" implementation - experience of the Barzilai University Medical Center (BUMC) Journal of the Neurological Sciences. 381: 410. DOI: 10.1016/J.Jns.2017.08.3371  0.01
2017 Dorodnicov E, Gelfand A, Milo R. Acute spinal cord ischemia treated with intravenous thrombolysis Journal of the Neurological Sciences. 381: 410. DOI: 10.1016/J.Jns.2017.08.3370  0.01
2016 Milo R, Stüve O. Spotlight on daclizumab: its potential in the treatment of multiple sclerosis. Degenerative Neurological and Neuromuscular Disease. 6: 95-109. PMID 30050372 DOI: 10.2147/DNND.S85747  0.01
2016 Noor E, Flamholz A, Bar-Even A, Davidi D, Milo R, Liebermeister W. The Protein Cost of Metabolic Fluxes: Prediction from Enzymatic Rate Laws and Cost Minimization. Plos Computational Biology. 12: e1005167. PMID 27812109 DOI: 10.1371/Journal.Pcbi.1005167  0.01
2016 Mangan NM, Flamholz A, Hood RD, Milo R, Savage DF. pH determines the energetic efficiency of the cyanobacterial CO2 concentrating mechanism. Proceedings of the National Academy of Sciences of the United States of America. PMID 27551079 DOI: 10.1073/Pnas.1525145113  0.01
2016 Keren L, Hausser J, Lotan-Pompan M, Vainberg Slutskin I, Alisar H, Kaminski S, Weinberger A, Alon U, Milo R, Segal E. Massively Parallel Interrogation of the Effects of Gene Expression Levels on Fitness. Cell. PMID 27545349 DOI: 10.1016/J.Cell.2016.07.024  1
2016 Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. Plos Biology. 14: e1002533. PMID 27541692 DOI: 10.1371/Journal.Pbio.1002533  0.01
2016 Eshel G, Shepon A, Noor E, Milo R. Environmentally Optimal, Nutritionally Aware Beef Replacement Plant-Based Diets. Environmental Science & Technology. 50: 8164-8. PMID 27387141 DOI: 10.1021/Acs.Est.6B01006  0.01
2016 Antonovsky N, Gleizer S, Noor E, Zohar Y, Herz E, Barenholz U, Zelcbuch L, Amram S, Wides A, Tepper N, Davidi D, Bar-On Y, Bareia T, Wernick DG, Shani I, ... ... Milo R, et al. Sugar Synthesis from CO2 in Escherichia coli. Cell. PMID 27345370 DOI: 10.1016/J.Cell.2016.05.064  1
2016 Lustig Y, Lanciotti RS, Hindiyeh M, Keller N, Milo R, Mayan S, Mendelson E. Mutation in West Nile Virus Structural Protein prM during Human Infection. Emerging Infectious Diseases. 22. PMID 27322782 DOI: 10.3201/Eid2209.160132  0.01
2016 Zelcbuch L, Lindner SN, Zegman Y, Vainberg Slutskin I, Antonovsky N, Gleizer S, Milo R, Bar-Even A. Pyruvate Formate-Lyase Enables Efficient Growth of Escherichia coli on Acetate and Formate. Biochemistry. 55: 2423-6. PMID 27093333 DOI: 10.1021/Acs.Biochem.6B00184  1
2016 Barenholz U, Keren L, Segal E, Milo R. A Minimalistic Resource Allocation Model to Explain Ubiquitous Increase in Protein Expression with Growth Rate. Plos One. 11: e0153344. PMID 27073913 DOI: 10.1371/Journal.Pone.0153344  1
2016 Milo R. Therapeutic strategies targeting B-cells in multiple sclerosis. Autoimmunity Reviews. 15: 714-8. PMID 26970489 DOI: 10.1016/J.Autrev.2016.03.006  0.01
2016 Shamir M, Bar-On Y, Phillips R, Milo R. SnapShot: Timescales in Cell Biology. Cell. 164: 1302-1302.e1. PMID 26967295 DOI: 10.1016/J.Cell.2016.02.058  0.01
2016 Davidi D, Noor E, Liebermeister W, Bar-Even A, Flamholz A, Tummler K, Barenholz U, Goldenfeld M, Shlomi T, Milo R. Global characterization of in vivo enzyme catalytic rates and their correspondence to in vitro kcat measurements. Proceedings of the National Academy of Sciences of the United States of America. 113: 3401-6. PMID 26951675 DOI: 10.1073/Pnas.1514240113  0.01
2016 Sender R, Fuchs S, Milo R. Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans. Cell. 164: 337-40. PMID 26824647 DOI: 10.1016/J.Cell.2016.01.013  0.04
2016 Shepon A, Eshel G, Noor E, Milo R. Energy and protein feed-to-food conversion efficiencies in the US and potential food security gains from dietary changes Environmental Research Letters. 11: 105002. DOI: 10.1088/1748-9326/11/10/105002  0.01
2016 Wernick D, Antonovsky N, Milo R. Engineering an evolutionary ladder for synthetic carbon fixation New Biotechnology. 33. DOI: 10.1016/J.Nbt.2016.06.773  0.01
2016 Nitsan Z, Gelfand A, Appel S, Tikhmanovich N, Dorodnicov E, Shenker A, Reznik-Tzoref J, Kahana E, Milo R. Infective endocarditis mimicking parkinsonism and rapidly progressive dementia European Geriatric Medicine. 7: 587-588. DOI: 10.1016/J.Eurger.2016.08.003  0.01
2015 Keren L, van Dijk D, Weingarten-Gabbay S, Davidi D, Jona G, Weinberger A, Milo R, Segal E. Noise in gene expression is coupled to growth rate. Genome Research. 25: 1893-902. PMID 26355006 DOI: 10.1101/Gr.191635.115  1
2015 Bar-Even A, Milo R, Noor E, Tawfik DS. The Moderately Efficient Enzyme: Futile Encounters and Enzyme Floppiness. Biochemistry. 54: 4969-77. PMID 26219075 DOI: 10.1021/Acs.Biochem.5B00621  1
2015 Kaushansky N, Eisenstein M, Boura-Halfon S, Hansen BE, Nielsen CH, Milo R, Zeilig G, Lassmann H, Altmann DM, Ben-Nun A. Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like Disease. The Journal of Biological Chemistry. 290: 15260-78. PMID 25911099 DOI: 10.1074/Jbc.M115.641209  0.01
2015 Zelcbuch L, Razo-Mejia M, Herz E, Yahav S, Antonovsky N, Kroytoro H, Milo R, Bar-Even A. An in vivo metabolic approach for deciphering the product specificity of glycerate kinase proves that both E. coli's glycerate kinases generate 2-phosphoglycerate. Plos One. 10: e0122957. PMID 25823014 DOI: 10.1371/Journal.Pone.0122957  1
2015 Eshel G, Shepon A, Makov T, Milo R. Reply to Tichenor: Proposed update to beef greenhouse gas footprint is numerically questionable and well within current uncertainty bounds. Proceedings of the National Academy of Sciences of the United States of America. 112: E822-3. PMID 25653340 DOI: 10.1073/Pnas.1422670112  0.01
2015 Milo R. Effectiveness of multiple sclerosis treatment with current immunomodulatory drugs. Expert Opinion On Pharmacotherapy. 16: 659-73. PMID 25582634 DOI: 10.1517/14656566.2015.1002769  0.01
2015 Wijmeersch BV, Oreja-Guevara C, Milo R. Can We Offer More to Patients with Multiple Sclerosis European Neurological Review. 10: 139. DOI: 10.17925/Enr.2015.10.02.139  0.01
2015 Eshel G, Shepon A, Makov T, Milo R. Partitioning United States' feed consumption among livestock categories for improved environmental cost assessments The Journal of Agricultural Science. 153: 432-445. DOI: 10.1017/S0021859614000690  0.01
2014 Eshel G, Shepon A, Makov T, Milo R. Reply to Metson et al.: The importance of phosphorus perturbations. Proceedings of the National Academy of Sciences of the United States of America. 111: E4908. PMID 25385649 DOI: 10.1073/Pnas.1418658111  0.01
2014 Flamholz A, Phillips R, Milo R. The quantified cell. Molecular Biology of the Cell. 25: 3497-500. PMID 25368429 DOI: 10.1091/Mbc.E14-09-1347  0.01
2014 Eshel G, Shepon A, Makov T, Milo R. Land, irrigation water, greenhouse gas, and reactive nitrogen burdens of meat, eggs, and dairy production in the United States. Proceedings of the National Academy of Sciences of the United States of America. 111: 11996-2001. PMID 25049416 DOI: 10.1073/Pnas.1402183111  0.01
2014 Liebermeister W, Noor E, Flamholz A, Davidi D, Bernhardt J, Milo R. Visual account of protein investment in cellular functions. Proceedings of the National Academy of Sciences of the United States of America. 111: 8488-93. PMID 24889604 DOI: 10.1073/Pnas.1314810111  1
2014 Farkash-Amar S, Zimmer A, Eden E, Cohen A, Geva-Zatorsky N, Cohen L, Milo R, Sigal A, Danon T, Alon U. Noise genetics: inferring protein function by correlating phenotype with protein levels and localization in individual human cells. Plos Genetics. 10: e1004176. PMID 24603725 DOI: 10.1371/Journal.Pgen.1004176  1
2014 Noor E, Bar-Even A, Flamholz A, Reznik E, Liebermeister W, Milo R. Pathway thermodynamics highlights kinetic obstacles in central metabolism. Plos Computational Biology. 10: e1003483. PMID 24586134 DOI: 10.1371/Journal.Pcbi.1003483  1
2014 Milo R, Miller A. Revised diagnostic criteria of multiple sclerosis. Autoimmunity Reviews. 13: 518-24. PMID 24424194 DOI: 10.1016/J.Autrev.2014.01.012  0.01
2014 Milo R. The efficacy and safety of daclizumab and its potential role in the treatment of multiple sclerosis. Therapeutic Advances in Neurological Disorders. 7: 7-21. PMID 24409199 DOI: 10.1177/1756285613504021  0.01
2013 Keren L, Zackay O, Lotan-Pompan M, Barenholz U, Dekel E, Sasson V, Aidelberg G, Bren A, Zeevi D, Weinberger A, Alon U, Milo R, Segal E. Promoters maintain their relative activity levels under different growth conditions. Molecular Systems Biology. 9: 701. PMID 24169404 DOI: 10.1038/Msb.2013.59  1
2013 Milo R. What is the total number of protein molecules per cell volume? A call to rethink some published values. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 35: 1050-5. PMID 24114984 DOI: 10.1002/Bies.201300066  0.01
2013 Tepper N, Noor E, Amador-Noguez D, Haraldsdóttir HS, Milo R, Rabinowitz J, Liebermeister W, Shlomi T. Steady-State Metabolite Concentrations Reflect a Balance between Maximizing Enzyme Efficiency and Minimizing Total Metabolite Load Plos One. 8. PMID 24086517 DOI: 10.1371/Journal.Pone.0075370  1
2013 Noor E, Flamholz A, Liebermeister W, Bar-Even A, Milo R. A note on the kinetics of enzyme action: a decomposition that highlights thermodynamic effects. Febs Letters. 587: 2772-7. PMID 23892083 DOI: 10.1016/J.Febslet.2013.07.028  0.01
2013 Noor E, Haraldsdóttir HS, Milo R, Fleming RM. Consistent estimation of Gibbs energy using component contributions. Plos Computational Biology. 9: e1003098. PMID 23874165 DOI: 10.1371/Journal.Pcbi.1003098  0.01
2013 Levin-Karp A, Barenholz U, Bareia T, Dayagi M, Zelcbuch L, Antonovsky N, Noor E, Milo R. Quantifying translational coupling in E. coli synthetic operons using RBS modulation and fluorescent reporters. Acs Synthetic Biology. 2: 327-36. PMID 23654261 DOI: 10.1021/Sb400002N  0.01
2013 Flamholz A, Noor E, Bar-Even A, Liebermeister W, Milo R. Glycolytic strategy as a tradeoff between energy yield and protein cost. Proceedings of the National Academy of Sciences of the United States of America. 110: 10039-44. PMID 23630264 DOI: 10.1073/Pnas.1215283110  0.01
2013 Zelcbuch L, Antonovsky N, Bar-Even A, Levin-Karp A, Barenholz U, Dayagi M, Liebermeister W, Flamholz A, Noor E, Amram S, Brandis A, Bareia T, Yofe I, Jubran H, Milo R. Spanning high-dimensional expression space using ribosome-binding site combinatorics. Nucleic Acids Research. 41: e98. PMID 23470993 DOI: 10.1093/Nar/Gkt151  0.01
2013 Bar-Even A, Noor E, Flamholz A, Milo R. Design and analysis of metabolic pathways supporting formatotrophic growth for electricity-dependent cultivation of microbes. Biochimica Et Biophysica Acta. 1827: 1039-47. PMID 23123556 DOI: 10.1016/J.Bbabio.2012.10.013  0.01
2013 Shepon A, Israeli T, Eshel G, Milo R. EcoTime—An intuitive quantitative sustainability indicator utilizing a time metric Ecological Indicators. 24: 240-245. DOI: 10.1016/J.Ecolind.2012.06.018  0.01
2012 Noor E, Lewis NE, Milo R. A proof for loop-law constraints in stoichiometric metabolic networks. Bmc Systems Biology. 6: 140. PMID 23146116 DOI: 10.1186/1752-0509-6-140  1
2012 Farkash-Amar S, Eden E, Cohen A, Geva-Zatorsky N, Cohen L, Milo R, Sigal A, Danon T, Alon U. Dynamic proteomics of human protein level and localization across the cell cycle. Plos One. 7: e48722. PMID 23144944 DOI: 10.1371/Journal.Pone.0048722  1
2012 Adadi R, Volkmer B, Milo R, Heinemann M, Shlomi T. Prediction of microbial growth rate versus biomass yield by a metabolic network with kinetic parameters. Plos Computational Biology. 8: e1002575. PMID 22792053 DOI: 10.1371/Journal.Pcbi.1002575  0.01
2012 Gur AY, Tanne D, Bornstein NM, Milo R, Auriel E, Shopin L, Koton S. Stroke in the Very Elderly: Characteristics and Outcome in Patients Aged ≥85 Years with a First-Ever Ischemic Stroke Neuroepidemiology. 39: 57-62. PMID 22777655 DOI: 10.1159/000339362  0.01
2012 Milo R, Last RL. Achieving diversity in the face of constraints: lessons from metabolism. Science (New York, N.Y.). 336: 1663-7. PMID 22745419 DOI: 10.1126/Science.1217665  1
2012 Noor E, Milo R. Evolution. Efficiency in evolutionary trade-offs. Science (New York, N.Y.). 336: 1114-5. PMID 22654045 DOI: 10.1126/Science.1223193  0.01
2012 Noor E, Bar-Even A, Flamholz A, Lubling Y, Davidi D, Milo R. An integrated open framework for thermodynamics of reactions that combines accuracy and coverage. Bioinformatics (Oxford, England). 28: 2037-44. PMID 22645166 DOI: 10.1093/Bioinformatics/Bts317  0.01
2012 Bar-Even A, Flamholz A, Noor E, Milo R. Thermodynamic constraints shape the structure of carbon fixation pathways. Biochimica Et Biophysica Acta. 1817: 1646-59. PMID 22609686 DOI: 10.1016/J.Bbabio.2012.05.002  0.01
2012 Bar-Even A, Flamholz A, Noor E, Milo R. Rethinking glycolysis: on the biochemical logic of metabolic pathways. Nature Chemical Biology. 8: 509-17. PMID 22596202 DOI: 10.1038/Nchembio.971  0.01
2012 Bar-Even A, Noor E, Milo R. A survey of carbon fixation pathways through a quantitative lens. Journal of Experimental Botany. 63: 2325-42. PMID 22200662 DOI: 10.1093/Jxb/Err417  0.01
2012 Flamholz A, Noor E, Bar-Even A, Milo R. eQuilibrator--the biochemical thermodynamics calculator. Nucleic Acids Research. 40: D770-5. PMID 22064852 DOI: 10.1093/Nar/Gkr874  0.01
2011 Hart Y, Mayo AE, Milo R, Alon U. Robust control of PEP formation rate in the carbon fixation pathway of C(4) plants by a bi-functional enzyme. Bmc Systems Biology. 5: 171. PMID 22024416 DOI: 10.1186/1752-0509-5-171  0.01
2011 Bar-Even A, Noor E, Flamholz A, Buescher JM, Milo R. Hydrophobicity and charge shape cellular metabolite concentrations. Plos Computational Biology. 7: e1002166. PMID 21998563 DOI: 10.1371/Journal.Pcbi.1002166  0.01
2011 Sigal A, Kim JT, Balazs AB, Dekel E, Mayo A, Milo R, Baltimore D. Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy. Nature. 477: 95-8. PMID 21849975 DOI: 10.1038/Nature10347  1
2011 Awad AM, Marder E, Milo R, Stüve O. Multiple sclerosis and chronic cerebrospinal venous insufficiency: a critical review. Therapeutic Advances in Neurological Disorders. 4: 231-5. PMID 21765873 DOI: 10.1177/1756285611405565  1
2011 Bar-Even A, Noor E, Savir Y, Liebermeister W, Davidi D, Tawfik DS, Milo R. The moderately efficient enzyme: evolutionary and physicochemical trends shaping enzyme parameters. Biochemistry. 50: 4402-10. PMID 21506553 DOI: 10.1021/Bi2002289  1
2011 Sellner J, Kraus J, Awad A, Milo R, Hemmer B, Stüve O. The increasing incidence and prevalence of female multiple sclerosis--a critical analysis of potential environmental factors. Autoimmunity Reviews. 10: 495-502. PMID 21354338 DOI: 10.1016/J.Autrev.2011.02.006  0.01
2011 Inzelberg R, Rabey JM, Melamed E, Djaldetti R, Reches A, Badarny S, Hassin-Baer S, Cohen O, Trau H, Aharon-Peretz J, Milo R, Schwartz M, Huberman M, Gilead L, Barchana M, et al. High prevalence of malignant melanoma in Israeli patients with Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 1199-207. PMID 21298300 DOI: 10.1007/S00702-011-0580-2  1
2011 Milo R, Panitch H. Combination therapy in multiple sclerosis. Journal of Neuroimmunology. 231: 23-31. PMID 21111490 DOI: 10.1016/J.Jneuroim.2010.10.021  0.01
2011 Meiner Z, Kahana E, Baitcher F, Korczyn AD, Chapman J, Cohen OS, Milo R, Aharon-Perez J, Abramsky O, Gabizon R, Rosenmann H. Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel Journal of Neurology. 258: 255-262. PMID 20827556 DOI: 10.1007/S00415-010-5738-6  1
2011 Alperovitch-Lavy A, Sharon I, Rohwer F, Aro EM, Glaser F, Milo R, Nelson N, Béjà O. Reconstructing a puzzle: existence of cyanophages containing both photosystem-I and photosystem-II gene suites inferred from oceanic metagenomic datasets. Environmental Microbiology. 13: 24-32. PMID 20649642 DOI: 10.1111/J.1462-2920.2010.02304.X  1
2011 Stüve O, Milo R. In Memoriam: Hillel S. Panitch, MD (1940-2010) Jama Neurology. 68: 681-681. DOI: 10.1001/Archneurol.2011.83  0.01
2010 Noor E, Eden E, Milo R, Alon U. Central carbon metabolism as a minimal biochemical walk between precursors for biomass and energy. Molecular Cell. 39: 809-20. PMID 20832731 DOI: 10.1016/J.Molcel.2010.08.031  0.01
2010 Stüve O, Kieseier BC, Hemmer B, Hartung HP, Awad A, Frohman EM, Greenberg BM, Racke MK, Zamvil SS, Phillips JT, Gold R, Chan A, Zettl U, Milo R, Marder E, et al. Translational research in neurology and neuroscience 2010: multiple sclerosis. Archives of Neurology. 67: 1307-15. PMID 20625066 DOI: 10.1001/Archneurol.2010.158  1
2010 Moran U, Phillips R, Milo R. SnapShot: key numbers in biology. Cell. 141: 1262-1262.e1. PMID 20603006 DOI: 10.1016/J.Cell.2010.06.019  0.01
2010 Bar-Even A, Noor E, Lewis NE, Milo R. Design and analysis of synthetic carbon fixation pathways. Proceedings of the National Academy of Sciences of the United States of America. 107: 8889-94. PMID 20410460 DOI: 10.1073/Pnas.0907176107  1
2010 Savir Y, Noor E, Milo R, Tlusty T. Cross-species analysis traces adaptation of Rubisco toward optimality in a low-dimensional landscape. Proceedings of the National Academy of Sciences of the United States of America. 107: 3475-80. PMID 20142476 DOI: 10.1073/Pnas.0911663107  0.01
2010 Milo R, Kahana E. Multiple sclerosis: Geoepidemiology, genetics and the environment Autoimmunity Reviews. 9. PMID 19932200 DOI: 10.1016/J.Autrev.2009.11.010  1
2010 Milo R, Jorgensen P, Moran U, Weber G, Springer M. BioNumbers--the database of key numbers in molecular and cell biology. Nucleic Acids Research. 38: D750-3. PMID 19854939 DOI: 10.1093/Nar/Gkp889  0.01
2009 Milo R, Schuldiner M. Weizmann Young PI forum: The power of peer support. Molecular Cell. 36: 913-5. PMID 20064454 DOI: 10.1016/J.Molcel.2009.12.008  0.01
2009 Milo R, Kalichman L, Volchek L, Reitblat T. Local corticosteroid treatment for carpal tunnel syndrome: a 6-month clinical and electrophysiological follow-up study. Journal of Back and Musculoskeletal Rehabilitation. 22: 59-64. PMID 20023332 DOI: 10.3233/Bmr-2009-0214  0.01
2009 Phillips R, Milo R. A feeling for the numbers in biology. Proceedings of the National Academy of Sciences of the United States of America. 106: 21465-71. PMID 20018695 DOI: 10.1073/Pnas.0907732106  0.01
2009 Milo R. What governs the reaction center excitation wavelength of photosystems I and II? Photosynthesis Research. 101: 59-67. PMID 19585266 DOI: 10.1007/S11120-009-9465-8  0.01
2009 Cohen AA, Kalisky T, Mayo A, Geva-Zatorsky N, Danon T, Issaeva I, Kopito RB, Perzov N, Milo R, Sigal A, Alon U. Protein dynamics in individual human cells: experiment and theory. Plos One. 4: e4901. PMID 19381343 DOI: 10.1371/Journal.Pone.0004901  1
2008 Cohen AA, Geva-Zatorsky N, Eden E, Frenkel-Morgenstern M, Issaeva I, Sigal A, Milo R, Cohen-Saidon C, Liron Y, Kam Z, Cohen L, Danon T, Perzov N, Alon U. Dynamic proteomics of individual cancer cells in response to a drug. Science (New York, N.Y.). 322: 1511-6. PMID 19023046 DOI: 10.1126/Science.1160165  1
2008 Sangster TA, Salathia N, Undurraga S, Milo R, Schellenberg K, Lindquist S, Queitsch C. HSP90 affects the expression of genetic variation and developmental stability in quantitative traits. Proceedings of the National Academy of Sciences of the United States of America. 105: 2963-8. PMID 18287065 DOI: 10.1073/Pnas.0712200105  1
2007 Shinar G, Milo R, Martínez MR, Alon U. Input output robustness in simple bacterial signaling systems. Proceedings of the National Academy of Sciences of the United States of America. 104: 19931-5. PMID 18077424 DOI: 10.1073/Pnas.0706792104  0.01
2007 Milo R, Hou JH, Springer M, Brenner MP, Kirschner MW. The relationship between evolutionary and physiological variation in hemoglobin. Proceedings of the National Academy of Sciences of the United States of America. 104: 16998-7003. PMID 17942680 DOI: 10.1073/Pnas.0707673104  1
2007 Milo R. Dynamic proteomics in mammalian cells: capabilities and challenges. Molecular Biosystems. 3: 542-6. PMID 17639129 DOI: 10.1039/B703639F  0.01
2007 Sigal A, Danon T, Cohen A, Milo R, Geva-Zatorsky N, Lustig G, Liron Y, Alon U, Perzov N. Generation of a fluorescently labeled endogenous protein library in living human cells. Nature Protocols. 2: 1515-27. PMID 17571059 DOI: 10.1038/Nprot.2007.197  1
2007 Spiegel I, Adamsky K, Eshed Y, Milo R, Sabanay H, Sarig-Nadir O, Horresh I, Scherer SS, Rasband MN, Peles E. A central role for Necl4 (SynCAM4) in Schwann cell-axon interaction and myelination. Nature Neuroscience. 10: 861-9. PMID 17558405 DOI: 10.1038/Nn1915  1
2007 Zaidel-Bar R, Milo R, Kam Z, Geiger B. A paxillin tyrosine phosphorylation switch regulates the assembly and form of cell-matrix adhesions. Journal of Cell Science. 120: 137-48. PMID 17164291 DOI: 10.1242/Jcs.03314  1
2006 Sigal A, Milo R, Cohen A, Geva-Zatorsky N, Klein Y, Liron Y, Rosenfeld N, Danon T, Perzov N, Alon U. Variability and memory of protein levels in human cells. Nature. 444: 643-6. PMID 17122776 DOI: 10.1038/Nature05316  1
2006 Sigal A, Milo R, Cohen A, Geva-Zatorsky N, Klein Y, Alaluf I, Swerdlin N, Perzov N, Danon T, Liron Y, Raveh T, Carpenter AE, Lahav G, Alon U. Dynamic proteomics in individual human cells uncovers widespread cell-cycle dependence of nuclear proteins. Nature Methods. 3: 525-31. PMID 16791210 DOI: 10.1038/Nmeth892  1
2006 Geva-Zatorsky N, Rosenfeld N, Itzkovitz S, Milo R, Sigal A, Dekel E, Yarnitzky T, Liron Y, Polak P, Lahav G, Alon U. Oscillations and variability in the p53 system. Molecular Systems Biology. 2: 2006.0033. PMID 16773083 DOI: 10.1038/Msb4100068  1
2005 Itzkovitz S, Levitt R, Kashtan N, Milo R, Itzkovitz M, Alon U. Coarse-graining and self-dissimilarity of complex networks. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics. 71: 016127. PMID 15697678 DOI: 10.1103/Physreve.71.016127  0.04
2004 Kertzman S, Aladjem Z, Milo R, Ben-Nahum Z, Birger M, Grinspan H, Weizman A, Kotler M. The utility of the Visual Analogue Scale for the assessment of depressive mood in cognitively impaired patients. International Journal of Geriatric Psychiatry. 19: 789-96. PMID 15290703 DOI: 10.1002/gps.1141  0.01
2004 Yeger-Lotem E, Sattath S, Kashtan N, Itzkovitz S, Milo R, Pinter RY, Alon U, Margalit H. Network motifs in integrated cellular networks of transcription-regulation and protein-protein interaction. Proceedings of the National Academy of Sciences of the United States of America. 101: 5934-9. PMID 15079056 DOI: 10.1073/Pnas.0306752101  0.01
2004 Milo R, Itzkovitz S, Kashtan N, Levitt R, Shen-Orr S, Ayzenshtat I, Sheffer M, Alon U. Superfamilies of evolved and designed networks. Science (New York, N.Y.). 303: 1538-42. PMID 15001784 DOI: 10.1126/Science.1089167  1
2004 Milo R, Itzkovitz S, Kashtan N, Levitt R, Alon U. Response to Comment on "Network Motifs: Simple Building Blocks of Complex Networks" and "Superfamilies of Evolved and Designed Networks" Science. 305: 1107-1107. DOI: 10.1126/Science.1100519  0.01
2004 Itzkovitz S, Milo R, Kashtan N, Newman MEJ, Alon U. Reply to ``Comment on `Subgraphs in random networks' '' Physical Review E. 70: 58102. DOI: 10.1103/Physreve.70.058102  0.01
2002 Milo R, Shen-Orr S, Itzkovitz S, Kashtan N, Chklovskii D, Alon U. Network motifs: simple building blocks of complex networks. Science (New York, N.Y.). 298: 824-7. PMID 12399590 DOI: 10.1126/Science.298.5594.824  1
2002 Klein C, Kimiagar I, Pollak L, Gandelman-Marton R, Itzhaki A, Milo R, Rabey JM. Neurological features of West Nile Virus infection during the 2000 outbreak in a regional hospital in Israel Journal of the Neurological Sciences. 200: 63-66. PMID 12127678 DOI: 10.1016/S0022-510X(02)00135-1  1
2002 Shen-Orr SS, Milo R, Mangan S, Alon U. Network motifs in the transcriptional regulation network of Escherichia coli. Nature Genetics. 31: 64-8. PMID 11967538 DOI: 10.1038/Ng881  1
2001 Pollak L, Milo R, Kossych V, Rabey MJ, Shapira E. Bilateral vestibular failure as a unique presenting sign in carcinomatous meningitis: case report Journal of Neurology, Neurosurgery, and Psychiatry. 70: 704-705. PMID 11336037 DOI: 10.1136/Jnnp.70.5.704  0.01
2000 Elkayam O, Paran D, Milo R, Davidovitz Y, Almoznino-Sarafian D, Zeltser D, Yaron M, Caspi D. Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases. Annals of the Rheumatic Diseases. 59: 77-80. PMID 10627434 DOI: 10.1136/Ard.59.1.77  1
1999 Milo R, Panitch H. Glatiramer Acetate or Interferon-β for Multiple Sclerosis? Cns Drugs. 11: 289-306. DOI: 10.2165/00023210-199911040-00005  0.01
1998 Li Q, Milo R, Panitch H, Swoveland P, Bever CT. Glatiramer acetate blocks the activation of THP-1 cells by interferon-gamma. European Journal of Pharmacology. 342: 303-10. PMID 9548401 DOI: 10.1016/S0014-2999(97)01509-4  0.01
1998 Li Q, Milo R, Panitch H, Bever CT. Effect of propranolol and IFN-beta on the induction of MHC class II expression and cytokine production by IFN-gamma IN THP-1 human monocytic cells. Immunopharmacology and Immunotoxicology. 20: 39-61. PMID 9543699 DOI: 10.3109/08923979809034808  0.04
1997 Flechter S, Fytlowitz S, Chen-Levi Z, Milo R, Rabey JM. 4-31-06 Serum cytokines and adhesion molecules in patients treated with interferon-beta 1b (betaferon), and copolymer-1 (copaxone): A one year follow-up Journal of the Neurological Sciences. 150. DOI: 10.1016/S0022-510X(97)86095-9  0.01
1996 Bever CT, Anderson PA, Leslie J, Panitch HS, Dhib-Jalbut S, Khan OA, Milo R, Hebel JR, Conway KL, Katz E, Johnson KP. Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial. Neurology. 47: 1457-62. PMID 8960727 DOI: 10.1212/Wnl.47.6.1457  1
1996 Dhib-Jalbut S, Gogate N, Milo R, Vergelli M, Martin R. Mechanisms of interferon-beta effect in multiple sclerosis Multiple Sclerosis Journal. 2: 254-254. DOI: 10.1177/135245859600200521  0.01
1995 Milo R, Panitch H. Additive effects of copolymer-1 and interferon beta-1b on the immune response to myelin basic protein. Journal of Neuroimmunology. 61: 185-93. PMID 7593554 DOI: 10.1016/0165-5728(95)00085-G  0.01
1995 Jiang H, Milo R, Swoveland P, Johnson KP, Panitch H, Dhib-Jalbut S. Interferon beta-1b reduces interferon gamma-induced antigen-presenting capacity of human glial and B cells. Journal of Neuroimmunology. 61: 17-25. PMID 7560008 DOI: 10.1016/0165-5728(95)00072-A  0.08
1995 Milo R, Jiang H, Dhib-Jalbut S, Swoveland P, Johnson KP, Panitch H. Interferonβ-1b reduces antigen presentation to human T-cells Journal of Neuroimmunology. 70-70. DOI: 10.1016/0165-5728(95)99105-R  0.01
1991 Arlazoroff A, Klein C, Meiner Z, Milo R, Theitler J, Carpel CL. Tiapride as treatment for certain patients with idiopathic torsion dystonia. European Neurology. 31: 356-359. PMID 1756758 DOI: 10.1159/000116693  0.01
1991 Awerbuch GI, Nigro MA, Sandyk R, Levin JR, Starkstein SE, Preziosi TJ, Robinson RG, Michotte A, Dequenne P, Jacobovitz D, Maeda Y, Kawasak Y, Jibiki I, Yamaguchi N, Matsuda H, ... ... Milo R, et al. Subject Index Vol. 31, 1991 European Neurology. 31: 437-438. DOI: 10.1159/000116714  0.01
1991 Awerbuch GI, Nigro MA, Sandyk R, Levin JR, Starkstein SE, Preziosi TJ, Robinson RG, Michotte A, Dequenne P, Jacobovitz D, Maeda Y, Kawasak Y, Jibiki I, Yamaguchi N, Matsuda H, ... ... Milo R, et al. Contents, Vol 31, 1991 European Neurology. 31. DOI: 10.1159/000116689  0.01
1991 Teitelbaum D, Milo R, Arnon R, Sela M. Specific inhibition by the synthetic copolymer COP-1 of human T cell lines specific to myelin basic protein Journal of Neuroimmunology. 35: 72. DOI: 10.1016/0165-5728(91)90970-I  0.01
1989 Milo R, Meuman M, Klein C, Caspi E, Arlazoroff A. Acute Intermittent Porphyria in Pregnancy Survey of Anesthesiology. 5: 307. DOI: 10.1097/00132586-198910000-00037  0.01
1989 Milo R, Neuman M, Klein C, Caspi E, Arlazoroff A. Acute intermittent porphyria in pregnancy International Journal of Gynecology & Obstetrics. 30: 82-82. DOI: 10.1016/0020-7292(89)90241-5  0.01
1985 Karpuch F, Schiffer F, Boldur I, Milo R, Sarfati S. Purulent meningitis due to Pseudomonas aeruginosa successfully treated with colistin and piperacillin Journal of Infection. 11: 272-274. PMID 4086872 DOI: 10.1016/S0163-4453(85)93426-7  0.01
Show low-probability matches.